Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T22:36:49.356Z.
Calculation as of: 2026-10-06T22:36:49.356Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1e37222dd90dbab5e03bfa1bbf20eaf6e61690ec1e62f49524765e66f30de265
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-03-17.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
EV/ASSETS RATIO AVG TTM
N/A
EV/ASSETS RATIO AVG 3Y
N/A
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$41.95M
EV/Assets Ratio
0.74x
TTM Avg
1.18x
3Y Avg
3.12x
5Y Avg
5.31x
Market Cap
$42.72M
EV/Assets Ratio
0.88x
TTM Avg
1.68x
3Y Avg
0.94x
5Y Avg
0.81x
Market Cap
$42.83M
EV/Assets Ratio
0.21x
TTM Avg
0.63x
3Y Avg
1.37x
5Y Avg
1.70x
Market Cap
$44.02M
EV/Assets Ratio
0.72x
TTM Avg
3.91x
3Y Avg
5.73x
5Y Avg
11.66x
Market Cap
$44.71M
EV/Assets Ratio
1.53x
TTM Avg
5.24x
3Y Avg
4.90x
5Y Avg
4.26x
Market Cap
$44.72M
EV/Assets Ratio
0.94x
TTM Avg
0.31x
3Y Avg
0.34x
5Y Avg
0.34x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $42.26M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | 0.74x | 1.18x | 3.12x | 5.31x |
| Precipio, Inc. (PRPO)vs › | $41.83M | 1.97x | 2.01x | 1.12x | 0.92x |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | 0.88x | 1.68x | 0.94x | 0.81x |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | 0.21x | 0.63x | 1.37x | 1.70x |
| CVRx, Inc. (CVRX)vs › | $42.99M | 0.41x | 1.41x | 1.81x | 1.54x |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 0.72x | 3.91x | 5.73x | 11.66x |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 1.53x | 5.24x | 4.90x | 4.26x |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | 0.94x | 0.31x | 0.34x | 0.34x |
| Veru Inc. (VERU)vs › | $39.64M | 0.50x | 0.80x | 3.63x | 5.12x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-03-17 | 0.01x |
| 2026-03-13 | 0.01x |
| 2026-03-10 | 0.07x |
| 2026-03-04 | 0.01x |
| 2026-03-03 | 0.01x |
| 2026-03-02 | 0.05x |
| 2026-02-27 | 0.03x |
| 2026-02-26 | 0.06x |
| 2026-02-25 | 0.02x |
| 2026-02-24 | 0.09x |
